• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

    3.980 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 651
    Open 3.980
    Bid (Size) 4.000 (1,900)
    Ask (Size) 4.180 (100)
    Prev. Close 3.980
    Today's Range 3.980 - 3.980
    52wk Range 1.620 - 5.055
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
    Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital 
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +51.9%
    +51.9%
    1 Month
    +27.8%
    +27.8%
    3 Month
    +109.5%
    +109.5%
    6 Month
    +74.6%
    +74.6%
    1 Year
    +19.2%
    +19.2%

    More News

    Read More
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    First Commercial Deployment of FDA-Cleared Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder and Other Neurological Conditions: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Government
    News headline image
    NRx (NRXP) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    Tuesday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    My Top 3 Biotech Stocks for May 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property
    News headline image
    NRx Pharmaceuticals Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma
    Via ACCESS Newswire
    News headline image
    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
    Via ACCESS Newswire
    News headline image
    New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
    Via ACCESS Newswire
    News headline image
    Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Government
    BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress
    Via Investor Brand Network
    News headline image
    NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program
    From NRx Pharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?
    NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market
    What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?
    The current price of NRX Pharmaceuticals, Inc. - Common Stock is 3.980
    When was NRX Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 06/17/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.